RWJ 67657 is an Orally Active and Selective p38α and p38β MAPK Inhibitor
MAPKs include many serine-threonine kinases. One of the major MAPK cascades is p38 MAPKs. p38 MAPK can serve as a potential therapeutic target for the treatment of not only inflammatory…